At the European AIDS Conference in Madrid, Dr. José Gatell talks with David Evans about the latest treatment news on Selzentry, rilpivirine (TMC278) and the continued interest in Kaletra monotherapy.
New Menu of Antiviral Options Dr. José Gatell talks with David Evans about the latest treatment news on Selzentry, rilpivirine (TMC278) and the continued interest in Kaletra monotherapy.
Children and Challenges: Treating Pediatric HIV Over 2 million children are living with HIV/AIDS throughout the world. Dr. José Ramos talks with Peter Staley about the unique challenges facing HIV-positive children and their health care providers.
October 26, 2007
Why Do Those With HIV Have More Heart Attacks? HIV and its medications may increase the risk of cardiovascular disease, but Dr. Jens Lundgren tells Peter Staley that there's a lot to be said for preventive strategies.
Aiming Low: 'Undetectable' Not Just for Treatment Newbies Dr. Jonathan Schapiro tells Peter Staley that an undetectable viral load is almost always an obtainable goal, even for highly treatment-experienced patients with drug-resistant HIV.
Dr. José Gatell talks with David Evans about the latest treatment news on Selzentry, rilpivirine (TMC278) and the continued interest in Kaletra monotherapy. 
Over 2 million children are living with HIV/AIDS throughout the world. Dr. José Ramos talks with Peter Staley about the unique challenges facing HIV-positive children and their health care providers. 
HIV and its medications may increase the risk of cardiovascular disease, but Dr. Jens Lundgren tells Peter Staley that there's a lot to be said for preventive strategies. 
Want to have a baby? Dr. Valerie Stone checks in with David Evans about family planning for couples living with HIV. 
Dr. Jonathan Schapiro tells Peter Staley that an undetectable viral load is almost always an obtainable goal, even for highly treatment-experienced patients with drug-resistant HIV.